AZ On The Rise In All Regions And Therapy Areas
The drug major's Q2 sales soared past consensus forecasts, driven by its three soon-to-be oncology blockbusters – Tagrisso, Imfinzi and Lynparza.
The drug major's Q2 sales soared past consensus forecasts, driven by its three soon-to-be oncology blockbusters – Tagrisso, Imfinzi and Lynparza.